chr9-65283327-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001126334.1(FOXD4L5):c.1051G>C(p.Ala351Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001126334.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 1AN: 145494Hom.: 0 Cov.: 20 FAILED QC
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000138 AC: 2AN: 1452168Hom.: 0 Cov.: 34 AF XY: 0.00000277 AC XY: 2AN XY: 722548
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000687 AC: 1AN: 145494Hom.: 0 Cov.: 20 AF XY: 0.00 AC XY: 0AN XY: 70418
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1051G>C (p.A351P) alteration is located in exon 1 (coding exon 1) of the FOXD4L5 gene. This alteration results from a G to C substitution at nucleotide position 1051, causing the alanine (A) at amino acid position 351 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at